1 - 25 of 2
Number of results to display per page
TitleDescriptionRelation Is Part OfDate
1 NEW TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSIS (LOU GEHRIG'S DISEASEThe preliminary analysis of a clinical trial of the drug riluzole, announced yesterday, shows it to be the first drug to have any impact on Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's Disease. Generally, patients survive three to five years after diagnosis of the disease. A preliminary study...Press Releases; University of Utah Health Sciences Center News1995-04-05
2 SYMPOSIUM WILL EXAMINE 30 YEARS OF PARTNERSHIP, PROGRESS AS U PHARMACY COLLEGE, NIH SEARCH FOR EPILEPSY MEDICATIONSSALT LAKE CITY - Thirty years and $42 million in research funding. Twenty-four thousand compounds and nine new epilepsy drugs.Press Releases; University of Utah Health Sciences Center News2004-10-13
1 - 25 of 2